Correlation Between WILLIS LEASE and BB Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both WILLIS LEASE and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining WILLIS LEASE and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between WILLIS LEASE FIN and BB Biotech AG, you can compare the effects of market volatilities on WILLIS LEASE and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in WILLIS LEASE with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of WILLIS LEASE and BB Biotech.

Diversification Opportunities for WILLIS LEASE and BB Biotech

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between WILLIS and BBZA is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding WILLIS LEASE FIN and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and WILLIS LEASE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on WILLIS LEASE FIN are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of WILLIS LEASE i.e., WILLIS LEASE and BB Biotech go up and down completely randomly.

Pair Corralation between WILLIS LEASE and BB Biotech

Assuming the 90 days horizon WILLIS LEASE FIN is expected to generate 3.14 times more return on investment than BB Biotech. However, WILLIS LEASE is 3.14 times more volatile than BB Biotech AG. It trades about 0.2 of its potential returns per unit of risk. BB Biotech AG is currently generating about 0.1 per unit of risk. If you would invest  16,480  in WILLIS LEASE FIN on September 1, 2024 and sell it today you would earn a total of  4,120  from holding WILLIS LEASE FIN or generate 25.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

WILLIS LEASE FIN  vs.  BB Biotech AG

 Performance 
       Timeline  
WILLIS LEASE FIN 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in WILLIS LEASE FIN are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, WILLIS LEASE reported solid returns over the last few months and may actually be approaching a breakup point.
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BB Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

WILLIS LEASE and BB Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with WILLIS LEASE and BB Biotech

The main advantage of trading using opposite WILLIS LEASE and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if WILLIS LEASE position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.
The idea behind WILLIS LEASE FIN and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated